Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Donna Reece

4PUBLICATIONS

32CO-AUTHORS

Gene and molecular therapyPredictive and prognostic markersTumour immunology

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Mar 11, 2026

Debulking Chemotherapy Can Overcome Primary Resistance to Teclistamab in Relapsed/Refractory Multiple Myeloma.

Rintu Sharma, Andree-Anne Pelland, Katherine Lajkosz

|Jan 27, 2026

Immunogenicity and safety of a third and subsequent COVID-19 vaccine doses in patients with plasma cell dyscrasias.

Sita Bhella, Gerard Agbayani, Katrina Hueniken

|Oct 09, 2025

Mel200 or BuMel conditioning in myeloma: is there a winner?

Donna E Reece

|Aug 13, 2023

Outcome of carfilzomib/pomalidomide-based regimens after daratumumab-based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis.

Richard LeBlanc, Hira Mian, Donna Reece

Pageof 1

Frequent Collaborators

2 joint publications

Esther Masih-Khan

2 joint publications

Christopher Venner

1 joint publications

Rintu Sharma

1 joint publications

Andree-Anne Pelland

1 joint publications

Katherine Lajkosz

1 joint publications

Harjot Singh Vohra

1 joint publications

Sita Bhella

1 joint publications

Christine I Chen

1 joint publications

Vishal Kukreti

1 joint publications

A Keith Stewart

Frequent Collaborators

2 joint publications

Esther Masih-Khan

2 joint publications

Christopher Venner

1 joint publications

Rintu Sharma

1 joint publications

Andree-Anne Pelland

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on : Feb 16, 2022

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on : Apr 01, 2015

See more related videos

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on : Feb 16, 2022

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on : Apr 01, 2015

See more related videos